Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q2 2025 Earnings Call Transcript August 14, 2025
Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-3.39, expectations were $-3.6.
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to Anne Marie Fields, Managing Director at Precision AQ. Please go ahead.
Anne Marie Fields:...
